CDH5 and neoplasm: In agreement, the highly angiogenic tumors developed in Lyl1-deficient mice exhibit sustained TAL1 expression with a concurrent up-expression of VE-Cadherin and ANG-2, while TAL1 was not detected in tumor vessels from wild-type mice [26].